Blue Star Shares Fall After Full-Year Guidance Cut Despite Q2 Profit Rise Blue Star shares fell 4.8% on Tuesday, marking their steepest intraday drop in six months, after the company reduced its full-year growth forecast despite posting steady second-quarter earnings. The company reported a 2.8% year-on-year increase in consolidated net profit to Rs 98.8 crore […]
Zydus Wellness Q2 Results: A Strategically Important Quarter Zydus Wellness Ltd. ‘s Q2 FY26 was a strategically important yet transitional quarter – strategic in direction but impacted by muted organic momentum amid GST-led disruption and seasonal weakness. Revenue Growth and Portfolio Expansion We reckon LFL revenues were flat and its non-seasonal portfolio grew in double
Zerodha’s Grayscale Mode: A Game-Changer for Indian Traders Zerodha, India’s largest stockbroker, is set to introduce a ‘Grayscale Mode’ on its Kite trading platform after Chief Executive Officer Nithin Kamath confirmed the feature was a ‘legit use case,’ following a viral social media post that highlighted the emotional toll of tracking portfolio performance. The Inspiration
Castrol India Q3 Review: IDBI Capital Maintains ‘Hold’, Sees Limited Upside Castrol India Ltd.’s Q3 performance was broadly in-line with expectations, driven by a 6% year-over-year (YoY) increase in sales. The growth was led by a 9% YoY volume growth, with the industrials segment witnessing double-digit growth and the commercial vehicle (CV) segment growing 8%
Ola Electric Shares Slide to Over Two-Month Low After Q2 Revenue Falls 43% Shares of Ola Electric Ltd. slipped on Friday morning to hit over two-month low after the company reported its second-quarter numbers, which saw the electric vehicle manufacturer post a 43% decline in revenue at Rs 690 crore from Rs 1,214 crore reported
Studds Accessories Shares Debut At 3% Discount Over IPO Price Studds Accessories Ltd. listed on the National Stock Exchange on Friday at Rs 565 apiece, a discount of 3.42% over its issue price of Rs 585 apiece. On the BSE, the stock debuted at Rs 570, a 2.56% discount. The initial public offering (IPO) of
Syngene International Q2 Review: Yes Securities Upgrades Stock to ‘Neutral’ Syngene International, a leading Indian biotechnology company, has been making significant strides in expanding its capabilities and augmenting its capacity in biologics. The company has commenced operations at its Unit III in Bengaluru, which is expected to contribute to its overall growth in the coming
Bharti Airtel Shares Fall Over 4% After Singtel Reportedly Offloads Stake Worth Rs 10,915 Crore The shares of Bharti Airtel Ltd. fell 4.35% on Friday after Singtel reportedly offloaded stake worth Rs 10,195 crore (Singaporean $1.15 billion). Singtel likely sold 0.8% stake in the telecom giant, reported Bloomberg. This significant development has sparked concerns among
LIC Q2 Review: ICICI Securities Maintains ‘Buy’ Call, Sees 23% Upside – Check Target Price Life Insurance Corporation of India (LIC) has witnessed a significant growth in its annual premium equivalent (APE) in the first half of FY26, with a 3.6% year-on-year (YoY) increase. The company’s strategic initiatives have also tracked well consistently, leading ICICI
GSK Pharma Q2 Review: A Closer Look at the Numbers GlaxoSmithKline Pharmaceuticals Ltd. recently reported its Q2 results, which showed a decline in revenue on a year-over-year (YoY) basis. This decline can be attributed to certain one-time events such as the GST transition and the fire incident at GSK Pharma’s contract manufacturing facility. Despite the